Leaflet GLICLAZIDA ACTAVIS 60mg modified release tablets
Indicated for: type 2 diabetes mellitus
Route of administration: oral
Substance: gliclazide (sulfonylurea antidiabetic)
ATC: A10BB09 (Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Sulfonylureas)
This medicine may lower blood sugar.
Gliclazide is an antidiabetic medication from the sulfonylurea class, used to control blood sugar levels in patients with type 2 diabetes. It works by stimulating the pancreas to produce more insulin, thereby helping to lower blood sugar levels.
It is recommended as part of a treatment plan that includes a balanced diet, regular physical activity, and blood sugar monitoring. Gliclazide is effective in preventing diabetes-related complications, such as damage to small blood vessels (retinopathy, nephropathy).
Side effects may include hypoglycemia (excessive drop in blood sugar), nausea, dizziness, or weight gain. It is important for patients to follow the prescribed dosage and watch for signs of hypoglycemia, such as shaking, sweating, or confusion.
General data about GLICLAZIDA ACTAVIS 60mg
- Substance: gliclazide
- Date of latest medicines list: 01-10-2015
- Product code: W61841005
- Concentration: 60mg
- Pharmaceutical form: modified release tablets
- Quantity: 56
- Product type: Generic medicine
- Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Pharmaceutical forms available for gliclazide
Concentrations available for gliclazide
- 30mg
- 60mg
- 80mg
- 90mg